
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mining Natural Products for Macrocycles to Drug Difficult Targets
Fabio Begnini, Vasanthanathan Poongavanam, Björn Over, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 2, pp. 1054-1072
Open Access | Times Cited: 39
Fabio Begnini, Vasanthanathan Poongavanam, Björn Over, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 2, pp. 1054-1072
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Electrochemical Late-Stage Functionalization
Yulei Wang, Suman Dana, Hao Long, et al.
Chemical Reviews (2023) Vol. 123, Iss. 19, pp. 11269-11335
Open Access | Times Cited: 133
Yulei Wang, Suman Dana, Hao Long, et al.
Chemical Reviews (2023) Vol. 123, Iss. 19, pp. 11269-11335
Open Access | Times Cited: 133
Macrocycles in Drug Discovery─Learning from the Past for the Future
Diego García Jiménez, Vasanthanathan Poongavanam, Jan Kihlberg
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5377-5396
Open Access | Times Cited: 128
Diego García Jiménez, Vasanthanathan Poongavanam, Jan Kihlberg
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5377-5396
Open Access | Times Cited: 128
KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
Enrique Crisman, Pablo Duarte, E. Daudén, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 237-287
Open Access | Times Cited: 114
Enrique Crisman, Pablo Duarte, E. Daudén, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 237-287
Open Access | Times Cited: 114
Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review
Jia Zheng, Wei Zhang, Linfeng Li, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 50
Jia Zheng, Wei Zhang, Linfeng Li, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 50
Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects
Giulia Culletta, Brigitta Buttari, Marzia Arese, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116355-116355
Closed Access | Times Cited: 13
Giulia Culletta, Brigitta Buttari, Marzia Arese, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116355-116355
Closed Access | Times Cited: 13
Cheminformatic analysis of natural product-based drugs and chemical probes
Samantha Stone, David Newman, Steven L. Colletti, et al.
Natural Product Reports (2021) Vol. 39, Iss. 1, pp. 20-32
Open Access | Times Cited: 44
Samantha Stone, David Newman, Steven L. Colletti, et al.
Natural Product Reports (2021) Vol. 39, Iss. 1, pp. 20-32
Open Access | Times Cited: 44
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
Dilip Narayanan, Kim T. Tran, Jakob S. Pallesen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14481-14526
Closed Access | Times Cited: 29
Dilip Narayanan, Kim T. Tran, Jakob S. Pallesen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14481-14526
Closed Access | Times Cited: 29
Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16
Macrocyclic DNA-encoded chemical libraries: a historical perspective
Louise Plais, Jörg Scheuermann
RSC Chemical Biology (2021) Vol. 3, Iss. 1, pp. 7-17
Open Access | Times Cited: 40
Louise Plais, Jörg Scheuermann
RSC Chemical Biology (2021) Vol. 3, Iss. 1, pp. 7-17
Open Access | Times Cited: 40
Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1–Nrf2 Protein–Protein Interaction
Fabio Begnini, Stefan Geschwindner, Patrik Johansson, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3473-3517
Open Access | Times Cited: 26
Fabio Begnini, Stefan Geschwindner, Patrik Johansson, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3473-3517
Open Access | Times Cited: 26
Mapping the binding sites of challenging drug targets
Amanda Wakefield, Dima Kozakov, Sándor Vajda
Current Opinion in Structural Biology (2022) Vol. 75, pp. 102396-102396
Open Access | Times Cited: 22
Amanda Wakefield, Dima Kozakov, Sándor Vajda
Current Opinion in Structural Biology (2022) Vol. 75, pp. 102396-102396
Open Access | Times Cited: 22
An updated patent review of Nrf2 activators (2020-present)
Ziquan Zhao, Ruitian Dong, Keni Cui, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 1, pp. 29-49
Closed Access | Times Cited: 15
Ziquan Zhao, Ruitian Dong, Keni Cui, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 1, pp. 29-49
Closed Access | Times Cited: 15
FDA‐approved drugs featuring macrocycles or medium‐sized rings
Youlong Du, Anas Semghouli, Qian Wang, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access
Youlong Du, Anas Semghouli, Qian Wang, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access
Effects of natural products on macrophage immunometabolism: a new frontier in the treatment of metabolic diseases
Jiani Li, Guo Chen, Xiaofei Yang, et al.
Pharmacological Research (2025), pp. 107634-107634
Open Access
Jiani Li, Guo Chen, Xiaofei Yang, et al.
Pharmacological Research (2025), pp. 107634-107634
Open Access
Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access
Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 11
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 11
A membrane permeability database for nonpeptidic macrocycles
Q. Feng, Danjo De Chavez, Jan Kihlberg, et al.
Scientific Data (2025) Vol. 12, Iss. 1
Open Access
Q. Feng, Danjo De Chavez, Jan Kihlberg, et al.
Scientific Data (2025) Vol. 12, Iss. 1
Open Access
The application and perspective of NMR and MS based strategies for functional compounds mining in medicinal and dietary plants
Bo‐Dou Zhang, Sheng Li, Zhenzhen Liang, et al.
Deleted Journal (2024)
Open Access | Times Cited: 3
Bo‐Dou Zhang, Sheng Li, Zhenzhen Liang, et al.
Deleted Journal (2024)
Open Access | Times Cited: 3
Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 3
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 3
Cell Permeability of Isomeric Macrocycles: Predictions and NMR Studies
Fabio Begnini, Vasanthanathan Poongavanam, Yoseph Atilaw, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 6, pp. 983-990
Open Access | Times Cited: 21
Fabio Begnini, Vasanthanathan Poongavanam, Yoseph Atilaw, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 6, pp. 983-990
Open Access | Times Cited: 21
Synthesis of Bioactive 1,2,3-Triazole-Fused Macrocycles via Azide-Alkyne Cycloaddition
Inul Ansary, Nasrin Jahan, Arkadip Pal
SynOpen (2023) Vol. 08, Iss. 01, pp. 1-38
Open Access | Times Cited: 7
Inul Ansary, Nasrin Jahan, Arkadip Pal
SynOpen (2023) Vol. 08, Iss. 01, pp. 1-38
Open Access | Times Cited: 7
Indole-Based Macrocyclization by Metal-Catalyzed Approaches
Subba Rao Cheekatla, Debashis Barik, Geethanjali Anand, et al.
Organics (2023) Vol. 4, Iss. 3, pp. 333-363
Open Access | Times Cited: 6
Subba Rao Cheekatla, Debashis Barik, Geethanjali Anand, et al.
Organics (2023) Vol. 4, Iss. 3, pp. 333-363
Open Access | Times Cited: 6
Marine diterpenoid targets STING palmitoylation in mammalian cells
Wan‐Chi Hsiao, Guang‐Hao Niu, Chen‐Fu Lo, et al.
Communications Chemistry (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Wan‐Chi Hsiao, Guang‐Hao Niu, Chen‐Fu Lo, et al.
Communications Chemistry (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Large-scale comparison of machine learning algorithms for target prediction of natural products
Liang Lu, Ye Liu, Bo-Kyeong Kang, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 9
Liang Lu, Ye Liu, Bo-Kyeong Kang, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 9